July 10, 2023
PLUVICTO™ Receives Positive Recommendations from CADTH and INESSS for Progressive PSMA-Positive Metastatic Castration-Resistant Prostate Cancer
May 18, 2023
Novartis Canada Launches New Head Office in the Health Innovation District of Montréal, Featuring a Unique Environment to Inspire Co-Creation, Partnerships and Continued Healthcare Innovation
March 1, 2023
Gene Replacement Therapy Luxturna® Now Reimbursed in Ontario for Adult and Pediatric Patients With a Rare Form of Inherited Vision Loss
No current content.